These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32647537)

  • 1. Diclofenac reduces the risk of Alzheimer's disease: a pilot analysis of NSAIDs in two US veteran populations.
    Stuve O; Weideman RA; McMahan DM; Jacob DA; Little BB
    Ther Adv Neurol Disord; 2020; 13():1756286420935676. PubMed ID: 32647537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effect of naproxen, etodolac and diclofenac on postoperative sequels following third molar surgery: a randomised, double-blind, crossover study.
    Akbulut N; Üstüner E; Atakan C; Çölok G
    Med Oral Patol Oral Cir Bucal; 2014 Mar; 19(2):e149-56. PubMed ID: 24316711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent clinical experience with etodolac in the treatment of osteoarthritis of the knee.
    Platt PN
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():54-62. PubMed ID: 2525984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia as a cellular target of diclofenac therapy in Alzheimer's disease.
    Stopschinski BE; Weideman RA; McMahan D; Jacob DA; Little BB; Chiang HS; Saez Calveras N; Stuve O
    Ther Adv Neurol Disord; 2023; 16():17562864231156674. PubMed ID: 36875711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk.
    Motsko SP; Rascati KL; Busti AJ; Wilson JP; Barner JC; Lawson KA; Worchel J
    Drug Saf; 2006; 29(7):621-32. PubMed ID: 16808554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dispensed selective and nonselective nonsteroidal anti-inflammatory drugs and the risk of moderate to severe hyperkalemia: a nested case-control study.
    Lafrance JP; Miller DR
    Am J Kidney Dis; 2012 Jul; 60(1):82-9. PubMed ID: 22503390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks of clinically significant upper gastrointestinal events with etodolac and naproxen: a historical cohort analysis.
    Weideman RA; Kelly KC; Kazi S; Cung A; Roberts KW; Smith HJ; Sarosi GA; Little BB; Cryer B
    Gastroenterology; 2004 Nov; 127(5):1322-8. PubMed ID: 15521001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
    Chen YF; Jobanputra P; Barton P; Bryan S; Fry-Smith A; Harris G; Taylor RS
    Health Technol Assess; 2008 Apr; 12(11):1-278, iii. PubMed ID: 18405470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of age, gender, Helicobacter pylori and smoking on gastric mucosal adaptation to non-steroidal anti-inflammatory drugs.
    Lipscomb GR; Campbell F; Rees WD
    Aliment Pharmacol Ther; 1997 Oct; 11(5):907-12. PubMed ID: 9354199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of nonsteroidal anti-inflammatory drugs and gastroprotective agents before the advent of cyclooxygenase-2-selective inhibitors: analysis of a large United States claims database.
    Schnitzer TJ; Kong SX; Mavros PP; Straus WL; Watson DJ
    Clin Ther; 2001 Dec; 23(12):1984-98. PubMed ID: 11813933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the knee.
    Watson MC; Brookes ST; Kirwan JR; Faulkner A
    Cochrane Database Syst Rev; 2000; (2):CD000142. PubMed ID: 10796306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative cardiovascular safety of nonsteroidal anti-inflammatory drugs in patients with hypertension: a population-based cohort study.
    Dong YH; Chang CH; Wu LC; Hwang JS; Toh S
    Br J Clin Pharmacol; 2018 May; 84(5):1045-1056. PubMed ID: 29468706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic and gastrointestinal safety comparisons of etodolac, nabumetone, and oxaprozin from insurance claims data from patients with arthritis.
    Simon LS; Zhao SZ; Arguelles LM; Lefkowith JB; Dedhiya SD; Fort JG; Johnson KE
    Clin Ther; 1998; 20(6):1218-35; discussion 1192-3. PubMed ID: 9916614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of acute myocardial infarction with etodolac is not increased compared to naproxen: a historical cohort analysis of a generic COX-2 selective inhibitor.
    Warner JJ; Weideman RA; Kelly KC; Brilakis ES; Banerjee S; Cunningham F; Harford WV; Kazi S; Little BB; Cryer B
    J Cardiovasc Pharmacol Ther; 2008 Dec; 13(4):252-60. PubMed ID: 18787084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.
    Jaturapatporn D; Isaac MG; McCleery J; Tabet N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD006378. PubMed ID: 22336816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etodolac, a new nonsteroidal anti-inflammatory drug: gastrointestinal microbleeding and endoscopic studies.
    Lanza FL; Arnold JD
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():5-15. PubMed ID: 2525983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended results of the Alzheimer's disease anti-inflammatory prevention trial.
    Breitner JC; Baker LD; Montine TJ; Meinert CL; Lyketsos CG; Ashe KH; Brandt J; Craft S; Evans DE; Green RC; Ismail MS; Martin BK; Mullan MJ; Sabbagh M; Tariot PN;
    Alzheimers Dement; 2011 Jul; 7(4):402-11. PubMed ID: 21784351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Clinical Effectiveness and Safety of Newer Nonsteroidal Anti-inflammatory Drugs in Patients of Osteoarthritis of Knee Joint: A Randomized, Prospective, Open-label Parallel-group Study.
    Garg Y; Singh J; Sohal HS; Gore R; Kumar A
    Indian J Pharmacol; 2017; 49(5):383-389. PubMed ID: 29515279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies.
    McGettigan P; Henry D
    PLoS Med; 2011 Sep; 8(9):e1001098. PubMed ID: 21980265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a follow-up study to the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT).
    Alzheimer's Disease Anti-inflammatory Prevention Trial Research Group
    Alzheimers Dement; 2013 Nov; 9(6):714-23. PubMed ID: 23562431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.